{"transactions":[{"id":459308,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2014-11-19T21:16:41.000Z","date":"2014-11-17","kind":"sale","acquired":false,"shares":33,"price":111.93,"value":3693.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1."}],"balance_after":43350,"source":{"system":"sec-edgar","filing":"0001209191-14-069991","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114069991/doc4.xml","form_type":"4"}},{"id":460119,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2014-11-03T22:45:34.000Z","date":"2014-10-30","kind":"grant","acquired":true,"shares":20000,"price":0.01,"value":200.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Performance-based retention award that will vest if performance objectives are achieved prior to November 15, 2019.  The award will vest on October 30, 2017 (or, if later, the day following the earnings release for the third quarter of 2017) if the Company achieves positive EBITDA for the 12-month period ending September 30, 2017.   Between January 1, 2018 and November 15, 2019, if the Company achieves positive EBITDA for a 12-month period ending on a calendar quarter, the award will vest on the day following  the applicable earnings release."}],"balance_after":43350,"source":{"system":"sec-edgar","filing":"0001209191-14-065912","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114065912/doc4.xml","form_type":"4"}},{"id":461083,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Stock Option (right to buy)","published_at":"2014-10-01T21:16:38.000Z","date":"2014-09-30","kind":"exercise","acquired":false,"shares":6875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"The option vests in 16 quarterly installments from 02/05/2014."}],"balance_after":48125,"derivative":{"exercise_price":77.31,"expiration_date":"2024-02-04","underlying":"Common Stock","underlying_shares":6875},"source":{"system":"sec-edgar","filing":"0001209191-14-060592","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114060592/doc4.xml","form_type":"4"}},{"id":461082,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Stock Option (right to buy)","published_at":"2014-10-01T21:16:38.000Z","date":"2014-09-30","kind":"exercise","acquired":false,"shares":6875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"The option vests in 16 quarterly installments from 07/30/2013."}],"balance_after":20625,"derivative":{"exercise_price":83.36,"expiration_date":"2023-07-29","underlying":"Common Stock","underlying_shares":6875},"source":{"system":"sec-edgar","filing":"0001209191-14-060592","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114060592/doc4.xml","form_type":"4"}},{"id":461081,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Stock Option (right to buy)","published_at":"2014-10-01T21:16:38.000Z","date":"2014-09-30","kind":"exercise","acquired":false,"shares":17157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"The option vests in 16 quarterly installments from 02/05/2013."}],"balance_after":28593,"derivative":{"exercise_price":45.11,"expiration_date":"2023-02-04","underlying":"Common Stock","underlying_shares":17157},"source":{"system":"sec-edgar","filing":"0001209191-14-060592","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114060592/doc4.xml","form_type":"4"}},{"id":461080,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Stock Option (right to buy)","published_at":"2014-10-01T21:16:38.000Z","date":"2014-09-30","kind":"exercise","acquired":false,"shares":15250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option vests in 16 quarterly installments from 07/25/2012."}],"balance_after":15250,"derivative":{"exercise_price":48.74,"expiration_date":"2022-07-24","underlying":"Common Stock","underlying_shares":15250},"source":{"system":"sec-edgar","filing":"0001209191-14-060592","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114060592/doc4.xml","form_type":"4"}},{"id":461079,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Stock Option (right to buy)","published_at":"2014-10-01T21:16:38.000Z","date":"2014-09-30","kind":"exercise","acquired":false,"shares":3532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"The option vests in 16 quarterly installments from 02/02/2012."}],"balance_after":4218,"derivative":{"exercise_price":37.86,"expiration_date":"2022-02-01","underlying":"Common Stock","underlying_shares":3532},"source":{"system":"sec-edgar","filing":"0001209191-14-060592","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114060592/doc4.xml","form_type":"4"}},{"id":461078,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Stock Option (right to buy)","published_at":"2014-10-01T21:16:38.000Z","date":"2014-09-30","kind":"exercise","acquired":false,"shares":5625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option vests in 16 quarterly installments from 07/13/2011."}],"balance_after":1875,"derivative":{"exercise_price":51.75,"expiration_date":"2021-07-12","underlying":"Common Stock","underlying_shares":5625},"source":{"system":"sec-edgar","filing":"0001209191-14-060592","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114060592/doc4.xml","form_type":"4"}},{"id":461077,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Stock Option (right to buy)","published_at":"2014-10-01T21:16:38.000Z","date":"2014-09-30","kind":"exercise","acquired":false,"shares":1172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests in 16 quarterly installments from 02/03/2011."}],"balance_after":2344,"derivative":{"exercise_price":38.8,"expiration_date":"2021-02-02","underlying":"Common Stock","underlying_shares":1172},"source":{"system":"sec-edgar","filing":"0001209191-14-060592","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114060592/doc4.xml","form_type":"4"}},{"id":461076,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2014-10-01T21:16:38.000Z","date":"2014-09-30","kind":"sale","acquired":false,"shares":11629,"price":113.9,"value":1324543.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Pace undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $113.90 (range $113.62 to $114.32)."}],"balance_after":23350,"source":{"system":"sec-edgar","filing":"0001209191-14-060592","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114060592/doc4.xml","form_type":"4"}},{"id":461075,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2014-10-01T21:16:38.000Z","date":"2014-09-30","kind":"sale","acquired":false,"shares":15400,"price":113.08,"value":1741432.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Pace undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $113.08 (range $112.61 to $113.59)."}],"balance_after":34979,"source":{"system":"sec-edgar","filing":"0001209191-14-060592","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114060592/doc4.xml","form_type":"4"}},{"id":461074,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2014-10-01T21:16:38.000Z","date":"2014-09-30","kind":"sale","acquired":false,"shares":21881,"price":112.21,"value":2455267.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Pace undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $112.21 (range $111.61 to $112.60)."}],"balance_after":50379,"source":{"system":"sec-edgar","filing":"0001209191-14-060592","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114060592/doc4.xml","form_type":"4"}},{"id":461073,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2014-10-01T21:16:38.000Z","date":"2014-09-30","kind":"sale","acquired":false,"shares":7576,"price":111.32,"value":843360.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $111.32 (range $110.61 to $111.60)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Pace undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":72260,"source":{"system":"sec-edgar","filing":"0001209191-14-060592","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114060592/doc4.xml","form_type":"4"}},{"id":461072,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2014-10-01T21:16:38.000Z","date":"2014-09-30","kind":"exercise","acquired":true,"shares":6875,"price":77.31,"value":531506.25,"ownership":{"direct":true},"balance_after":79836,"source":{"system":"sec-edgar","filing":"0001209191-14-060592","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114060592/doc4.xml","form_type":"4"}},{"id":461071,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2014-10-01T21:16:38.000Z","date":"2014-09-30","kind":"exercise","acquired":true,"shares":6875,"price":83.36,"value":573100.0,"ownership":{"direct":true},"balance_after":72961,"source":{"system":"sec-edgar","filing":"0001209191-14-060592","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114060592/doc4.xml","form_type":"4"}},{"id":461070,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2014-10-01T21:16:38.000Z","date":"2014-09-30","kind":"exercise","acquired":true,"shares":17157,"price":45.11,"value":773952.27,"ownership":{"direct":true},"balance_after":66086,"source":{"system":"sec-edgar","filing":"0001209191-14-060592","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114060592/doc4.xml","form_type":"4"}},{"id":461069,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2014-10-01T21:16:38.000Z","date":"2014-09-30","kind":"exercise","acquired":true,"shares":15250,"price":48.74,"value":743285.0,"ownership":{"direct":true},"balance_after":48929,"source":{"system":"sec-edgar","filing":"0001209191-14-060592","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114060592/doc4.xml","form_type":"4"}},{"id":461068,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2014-10-01T21:16:38.000Z","date":"2014-09-30","kind":"exercise","acquired":true,"shares":3532,"price":37.86,"value":133721.52,"ownership":{"direct":true},"balance_after":33679,"source":{"system":"sec-edgar","filing":"0001209191-14-060592","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114060592/doc4.xml","form_type":"4"}},{"id":461067,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2014-10-01T21:16:38.000Z","date":"2014-09-30","kind":"exercise","acquired":true,"shares":5625,"price":51.75,"value":291093.75,"ownership":{"direct":true},"balance_after":30147,"source":{"system":"sec-edgar","filing":"0001209191-14-060592","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114060592/doc4.xml","form_type":"4"}},{"id":461066,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2014-10-01T21:16:38.000Z","date":"2014-09-30","kind":"exercise","acquired":true,"shares":1172,"price":38.8,"value":45473.6,"ownership":{"direct":true},"balance_after":24522,"source":{"system":"sec-edgar","filing":"0001209191-14-060592","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114060592/doc4.xml","form_type":"4"}},{"id":463198,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Stock Option","published_at":"2014-07-17T22:28:06.000Z","date":"2014-07-15","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 16 quarterly installments from 07/15/2014."}],"balance_after":27500,"derivative":{"exercise_price":96.87,"expiration_date":"2024-07-14","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001209191-14-047903","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114047903/doc4.xml","form_type":"4"}},{"id":463818,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Stock Option (righty to buy)","published_at":"2014-06-26T20:50:35.000Z","date":"2014-06-24","kind":"exercise","acquired":false,"shares":5234,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 2/3/2011."}],"balance_after":3516,"derivative":{"exercise_price":38.8,"expiration_date":"2021-02-02","underlying":"Common Stock","underlying_shares":5234},"source":{"system":"sec-edgar","filing":"0001209191-14-043875","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114043875/doc4.xml","form_type":"4"}},{"id":463817,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Stock Option (right to buy)","published_at":"2014-06-26T20:50:35.000Z","date":"2014-06-24","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":37.29,"expiration_date":"2020-05-09","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-14-043875","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114043875/doc4.xml","form_type":"4"}},{"id":463816,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2014-06-26T20:50:35.000Z","date":"2014-06-24","kind":"sale","acquired":false,"shares":12734,"price":98.03,"value":1248314.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1."}],"balance_after":23350,"source":{"system":"sec-edgar","filing":"0001209191-14-043875","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114043875/doc4.xml","form_type":"4"}},{"id":463815,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2014-06-26T20:50:35.000Z","date":"2014-06-24","kind":"exercise","acquired":true,"shares":5234,"price":38.8,"value":203079.2,"ownership":{"direct":true},"balance_after":36084,"source":{"system":"sec-edgar","filing":"0001209191-14-043875","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114043875/doc4.xml","form_type":"4"}},{"id":463814,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2014-06-26T20:50:35.000Z","date":"2014-06-24","kind":"exercise","acquired":true,"shares":7500,"price":37.29,"value":279675.0,"ownership":{"direct":true},"balance_after":30850,"source":{"system":"sec-edgar","filing":"0001209191-14-043875","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114043875/doc4.xml","form_type":"4"}},{"id":464787,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2014-05-19T20:16:08.000Z","date":"2014-05-15","kind":"sale","acquired":false,"shares":22,"price":67,"value":1474.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1."}],"balance_after":23350,"source":{"system":"sec-edgar","filing":"0001209191-14-035067","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114035067/doc4.xml","form_type":"4"}},{"id":464786,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2014-05-19T20:16:08.000Z","date":"2014-05-15","kind":"sale","acquired":false,"shares":347,"price":65.57,"value":22752.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $65.57 (range $65.22 to $66.09)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Pace undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":23372,"source":{"system":"sec-edgar","filing":"0001209191-14-035067","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114035067/doc4.xml","form_type":"4"}},{"id":465232,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2014-05-06T20:30:43.000Z","date":"2014-05-02","kind":"sale","acquired":false,"shares":100,"price":69.42,"value":6942.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1."}],"balance_after":23350,"source":{"system":"sec-edgar","filing":"0001209191-14-031519","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114031519/doc4.xml","form_type":"4"}},{"id":465231,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2014-05-06T20:30:43.000Z","date":"2014-05-02","kind":"sale","acquired":false,"shares":400,"price":67.94,"value":27176.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Ms. Pace undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $67.94 (range $67.73 to $68.24)."}],"balance_after":23450,"source":{"system":"sec-edgar","filing":"0001209191-14-031519","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114031519/doc4.xml","form_type":"4"}},{"id":465230,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2014-05-06T20:30:43.000Z","date":"2014-05-02","kind":"sale","acquired":false,"shares":500,"price":67.01,"value":33505.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Ms. Pace undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $67.01 (range $66.49 to $67.40)."}],"balance_after":23850,"source":{"system":"sec-edgar","filing":"0001209191-14-031519","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114031519/doc4.xml","form_type":"4"}},{"id":469333,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Employee Stock Option (right to buy)","published_at":"2014-02-07T21:06:51.000Z","date":"2014-02-05","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 16 quarterly installments from 02/05/2014."}],"balance_after":55000,"derivative":{"exercise_price":77.31,"expiration_date":"2024-02-04","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001209191-14-008357","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114008357/doc4.xml","form_type":"4"}},{"id":469332,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2014-02-07T21:06:51.000Z","date":"2014-02-05","kind":"grant","acquired":true,"shares":14250,"price":0.01,"value":142.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant under 2006 Stock and Option Plan, vesting on 2/5/2018, subject to (i) acceleration of 50% of shares upon (a) reaching a specified net product sales level over a one-year period for a combination regimen that includes ivacaftor and a CFTR corrector or (b) dosing of the first patient in the first clinical trial to evaluate a second-generation CFTR corrector compound and (ii) acceleration of 50% of shares upon (a) dosing of the first patient in a pivotal trial for a regimen including VX-661 or a specified cancer compound or (b) reaching a specified net product sales level over a one-year period for all our products."}],"balance_after":24350,"source":{"system":"sec-edgar","filing":"0001209191-14-008357","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114008357/doc4.xml","form_type":"4"}},{"id":470212,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2014-01-23T21:15:47.000Z","date":"2014-01-21","kind":"sale","acquired":false,"shares":1250,"price":85,"value":106250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1."}],"balance_after":10100,"source":{"system":"sec-edgar","filing":"0001209191-14-004556","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114004556/doc4.xml","form_type":"4"}},{"id":470556,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2014-01-08T21:19:23.000Z","date":"2014-01-06","kind":"sale","acquired":false,"shares":838,"price":75,"value":62850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1."}],"balance_after":11350,"source":{"system":"sec-edgar","filing":"0001209191-14-002375","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919114002375/doc4.xml","form_type":"4"}},{"id":471349,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2013-12-12T22:51:39.000Z","date":"2013-12-12","kind":"sale","acquired":false,"shares":5083,"price":65.48,"value":332834.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $65.48 (range $65.05 to $65.91)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Pace undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":12188,"source":{"system":"sec-edgar","filing":"0001209191-13-056699","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919113056699/doc4.xml","form_type":"4"}},{"id":472448,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2013-11-19T21:19:21.000Z","date":"2013-11-15","kind":"sale","acquired":false,"shares":93,"price":60.97,"value":5670.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1."}],"balance_after":17271,"source":{"system":"sec-edgar","filing":"0001209191-13-053085","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919113053085/doc4.xml","form_type":"4"}},{"id":475548,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Stock Option","published_at":"2013-08-01T20:12:47.000Z","date":"2013-07-30","kind":"grant","acquired":true,"shares":27500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 16 quarterly installments from 07/30/2013."}],"balance_after":27500,"derivative":{"exercise_price":83.36,"expiration_date":"2023-07-29","underlying":"Common Stock","underlying_shares":27500},"source":{"system":"sec-edgar","filing":"0001209191-13-038692","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919113038692/doc4.xml","form_type":"4"}},{"id":475924,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Stock Option","published_at":"2013-07-15T20:10:41.000Z","date":"2013-07-12","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 16 quarterly installments from 02/03/2011."}],"balance_after":8750,"derivative":{"exercise_price":38.8,"expiration_date":"2021-02-02","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-13-036628","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919113036628/doc4.xml","form_type":"4"}},{"id":475923,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Stock Option","published_at":"2013-07-15T20:10:41.000Z","date":"2013-07-11","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in 16 quarterly installments from 02/03/2011."}],"balance_after":13750,"derivative":{"exercise_price":38.8,"expiration_date":"2021-02-02","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-13-036628","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919113036628/doc4.xml","form_type":"4"}},{"id":475922,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2013-07-15T20:10:41.000Z","date":"2013-07-12","kind":"sale","acquired":false,"shares":5000,"price":86,"value":430000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1."}],"balance_after":17271,"source":{"system":"sec-edgar","filing":"0001209191-13-036628","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919113036628/doc4.xml","form_type":"4"}},{"id":475921,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2013-07-15T20:10:41.000Z","date":"2013-07-12","kind":"sale","acquired":false,"shares":678,"price":85,"value":57630.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1."}],"balance_after":22271,"source":{"system":"sec-edgar","filing":"0001209191-13-036628","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919113036628/doc4.xml","form_type":"4"}},{"id":475920,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2013-07-15T20:10:41.000Z","date":"2013-07-12","kind":"exercise","acquired":true,"shares":5000,"price":38.8,"value":194000.0,"ownership":{"direct":true},"balance_after":22949,"source":{"system":"sec-edgar","filing":"0001209191-13-036628","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919113036628/doc4.xml","form_type":"4"}},{"id":475919,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2013-07-15T20:10:41.000Z","date":"2013-07-11","kind":"sale","acquired":false,"shares":5000,"price":84,"value":420000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1."}],"balance_after":17949,"source":{"system":"sec-edgar","filing":"0001209191-13-036628","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919113036628/doc4.xml","form_type":"4"}},{"id":475918,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2013-07-15T20:10:41.000Z","date":"2013-07-11","kind":"exercise","acquired":true,"shares":5000,"price":38.8,"value":194000.0,"ownership":{"direct":true},"balance_after":22949,"source":{"system":"sec-edgar","filing":"0001209191-13-036628","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919113036628/doc4.xml","form_type":"4"}},{"id":476024,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Stock Option","published_at":"2013-07-10T20:44:31.000Z","date":"2013-07-08","kind":"exercise","acquired":false,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option vests in 16 quarterly installments from 02/02/2012."}],"balance_after":7750,"derivative":{"exercise_price":37.86,"expiration_date":"2022-02-01","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001209191-13-036102","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919113036102/doc4.xml","form_type":"4"}},{"id":476023,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Stock Option","published_at":"2013-07-10T20:44:31.000Z","date":"2013-07-08","kind":"exercise","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option vests in 16 quarterly installments from 05/10/2010."}],"balance_after":7500,"derivative":{"exercise_price":37.29,"expiration_date":"2020-05-09","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001209191-13-036102","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919113036102/doc4.xml","form_type":"4"}},{"id":476022,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2013-07-10T20:44:31.000Z","date":"2013-07-08","kind":"sale","acquired":false,"shares":4100,"price":82.46,"value":338086.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Pace undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $82.46 (range $82.03 to $82.70)."}],"balance_after":17949,"source":{"system":"sec-edgar","filing":"0001209191-13-036102","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919113036102/doc4.xml","form_type":"4"}},{"id":476021,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2013-07-10T20:44:31.000Z","date":"2013-07-08","kind":"sale","acquired":false,"shares":3400,"price":81.54,"value":277236.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Pace undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $81.54 (range $81.04 to $81.88)."}],"balance_after":22049,"source":{"system":"sec-edgar","filing":"0001209191-13-036102","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919113036102/doc4.xml","form_type":"4"}},{"id":476020,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2013-07-10T20:44:31.000Z","date":"2013-07-08","kind":"sale","acquired":false,"shares":21203,"price":80.48,"value":1706417.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Pace's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $80.48 (range $80.04 to $80.91)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Pace undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":25449,"source":{"system":"sec-edgar","filing":"0001209191-13-036102","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919113036102/doc4.xml","form_type":"4"}},{"id":476019,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2013-07-10T20:44:31.000Z","date":"2013-07-08","kind":"exercise","acquired":true,"shares":3500,"price":37.86,"value":132510.0,"ownership":{"direct":true},"balance_after":46652,"source":{"system":"sec-edgar","filing":"0001209191-13-036102","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919113036102/doc4.xml","form_type":"4"}},{"id":476018,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2013-07-10T20:44:31.000Z","date":"2013-07-08","kind":"exercise","acquired":true,"shares":22500,"price":37.29,"value":839025.0,"ownership":{"direct":true},"balance_after":43152,"source":{"system":"sec-edgar","filing":"0001209191-13-036102","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919113036102/doc4.xml","form_type":"4"}},{"id":482330,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Employee Stock Option (right to buy)","published_at":"2013-02-07T22:33:16.000Z","date":"2013-02-05","kind":"grant","acquired":true,"shares":45750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/05/2013."}],"balance_after":45750,"derivative":{"exercise_price":45.11,"expiration_date":"2023-02-04","underlying":"Common Stock","underlying_shares":45750},"source":{"system":"sec-edgar","filing":"0001209191-13-007129","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919113007129/doc4.xml","form_type":"4"}},{"id":482329,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Common Stock","published_at":"2013-02-07T22:33:16.000Z","date":"2013-02-05","kind":"grant","acquired":true,"shares":10166,"price":0.01,"value":101.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Stock grant under 2006 Stock and Option Plan, vesting on 2/5/2017, subject to (i) acceleration of 50% of shares upon (a) receiving filing confirmation for an NDA for a combination regimen that includes both ivacaftor and a corrector compound or (b) receiving filing confirmation for an sNDA that would increase the number of patients with CF eligible for ivacaftor monotherapy, and (ii) acceleration of 50% of shares upon (a) the announcement of proof-of-concept data for a drug candidate other than an HCV, cystic fibrosis, influenza or JAK3 inhibition drug candidate or (b) reaching a specified net sales level over a twelve month period for our CF products."}],"balance_after":19915,"source":{"system":"sec-edgar","filing":"0001209191-13-007129","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919113007129/doc4.xml","form_type":"4"}},{"id":489634,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":16474,"kind":"person","name":"Pace Megan E","position":1,"cik":"0001554979","reported_name":"Pace Megan E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Corp. Communications"}}],"security":"Employee Stock Option (right to buy)","published_at":"2012-07-26T21:02:49.000Z","date":"2012-07-25","kind":"grant","acquired":true,"shares":30500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 16 quarterly installments beginning on 10/25/2012."}],"balance_after":30500,"derivative":{"exercise_price":48.74,"expiration_date":"2022-07-24","underlying":"Common Stock","underlying_shares":30500},"source":{"system":"sec-edgar","filing":"0001209191-12-039172","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919112039172/doc4.xml","form_type":"4"}}]}